FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Cell-Free DNA BCT
K Number: K231776
·
Decision Jul 26, 2024
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
1
Applicant Total
3
Review Days
406
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Cell-Free DNA BCT
- K Number
- K231776
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.1676
- Medical Specialty
- Clinical Chemistry
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Streck, Inc.
- Date Received
- June 16, 2023
- Decision Date
- July 26, 2024
- Product Code
- QMA
- Advisory Committee
- Clinical Chemistry
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QMA | Blood Collection Device For Cell-Free Nucleic Acid | FDA class 2 | Clinical Chemistry |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (QMA), ordered by most recent decision date.
View all